WHO Home Page

Office of the Director-General

World Health Organization
Organisation mondiale de la Santé

UPDATED: Mon Feb 18 16:59:04 2002

Dr Gro Harlem Brundtland        
Director-General
World Health Organization

Brussels
 30 May 2001

   

Pre-Council Dinner with the Development Cooperation Ministers of the European Union

Distinguished Ministers,

It is a great pleasure for me to be invited to join you here tonight.

As many of you know, I came into my current position with a strong belief that good health and environment is inseparably linked to development. In my first year, I set up the Commission on Macroeconomics and Health to provide the evidence base for these links and for developing strategies on how health can play a constructive role in the development process. We expect its report at the end of the year.

An early opportunity to discuss these issues came in London in May, two years ago, when Claire Short kindly hosted a conference of heads of developing agencies named "World Health Opportunity - developing health, reducing poverty".

Looking back, that conference set in motion a process which over the past two years has gained momentum. It joined other streams of thought and energy and now they together have grown into a formidable river.

The issues that we discussed in London have by now become widely accepted realities: major diseases, such as HIV/AIDS, malaria and TB directly affect the poorest countries' ability to develop. They function as a drag on economic growth and they perpetuate poverty. Childhood illnesses and maternal conditions also hamper efforts to give the poorest a chance to get out of the vicious cycles of deprivation and despair.

In addition, changing lifestyles, linked to growing urbanization, pollution and the onslaught of tobacco marketing in developing countries, give these nations a double burden of disease to cope with - a burden their under-funded national budgets and weak health sectors can ill afford. Investing in poor people's health is a pre-requisite for other development-spurring activities.

The European Union has played an significant role in this - with the energetic guidance of Commissioner Poul Nielson and his colleagues. Through the Communication on communicable diseases, adopted last year by the Council of Development Ministers, which in turn led to an EC Programme for Action for the five year period leading up to 2006, you have marked up a route to pursue, in order to reach the internationally agreed targets of halving malaria and TB by 2010 and reducing new HIV infections by 25%.

The strong link between the three main elements of the planned action is particularly important: ensuring optimal impact from existing interventions; increasing the affordability of key pharmaceuticals; and increased investment in research and development.

Over the past year, the renewed public concern over HIV/AIDS and the devastation it is bringing on large parts of the developing world has brought the link between disease and development onto the global political agenda. The progress we are seeing towards a new fund to fight HIV/AIDS, TB and malaria is impressive and heartening. It is also an extraordinary and trail blazing process.

Governments from industrialized and developing countries alike are coming together with a coordinated United Nations family to produce a new and path-breaking mechanism for action against diseases that perpetuate poverty.

But before I say more about the proposed Global AIDS and Health Fund, let me say a few words about the context within which it is being created.

Over the past few months, we have seen a growing commitment to a new international framework which links the availability of new resources to the ways in which they are used.

The first element of this framework is that there really is a steep increase in resources. The United Nations Secretary-General has spoken of an additional US$ 7 billion per year for HIV/AIDS. I believe we should be looking toward a progressive increase in funding - from all sources, both national and international - toward a total of about US$ 10 billion a year to cover the investments needed to tackle HIV, tuberculosis and malaria.

The second element is ensuring that essential global functions take place, such as programmes of strategic research for, and development of, necessary drugs and vaccines and strategic partnerships to bring down medicine prices in order to improve access in poorer communities.

But we also will need schemes for the efficient purchase and equitable distribution of critical commodities, obviously in ways that respect intellectual property, that build on existing international trade agreements and that show how to take advantage of the new advances in biotechnology. The Trade Commissioner, Pascal Lamy, has played a key role in working to this end.

The third element in this framework is innovative and urgent action to secure the effective operation of health systems even when they are seriously under-funded. This means improving the capacity of a variety of different provider groups to deliver essential services and goods through a diversity of private, voluntary and public channels. The emphasis must be on stewardship by governments, even in complex emergencies. Effective stewardship calls for the strengthening of human resource capacity through development of leadership and public health skills, coupled with efforts to retain critical staff. This would be backed by focused investment in essential infrastructure, fair systems for health financing, logistics for storing and distributing medicines and other vital commodities, functioning laboratory services, and - importantly - monitoring the quality and coverage of all services.

The overall goal would be to ensure that health systems are able to deliver services that are as effective, responsive and fairly financed as possible given the resources available.

The fourth element is to ensure the independent authoritative monitoring and review of results, relating these to investments, accompanied by rapid reporting and public relations - in order to sustain long-term involvement.

The fifth element is to catalyse intense and social mobilization at country and global levels, through a credible and upbeat programme of advocacy with political leaders and key public figures. It would work through governments, NGOs, and the media. It would be based on the theme of working together to "make the forces of globalization work for the secure future of humanity ".

Last, but not least, we need an effective, fast mechanism for moving money. This brings us to the proposed Fund.

The purpose of the proposed Fund is to mobilize, manage and disburse additional and complementary grant resources - enabling countries to achieve more rapid progress in addressing the development, economic and human security challenges created by HIV/AIDS, malaria and TB.

Let me briefly sum up how I see the evolving consensus. There are 11 points here.

  • The Fund should not replace existing financing mechanisms but should enhance existing efforts.
  • It should support on-going national development processes, such as poverty reduction strategies, sector programmes, and national HIV/AIDS strategies.

  • It should increase the effectiveness of international assistance, and foster convergence between disease-specific initiatives.

  • It should encourage voluntary and private sector participation in the management and provision of services at the country level.

  • It should encourage new ways of working, including rapid and effective fund disbursement - without compromising accountability.

  • It should be transparent and flexible: avoid new and elaborate planning processes. The review criteria should be transparent and consistently applied.

  • It should decrease transaction costs: for donors and national governments.

  • It should focus on results, with clear indicators in all proposals - rewarding good performance.

  • One size does not fit all: operation of the Fund must be geared to different national contexts.

  • It should have effective but light governance.

  • It should be consistent with international agreements and therefore work within the context of TRIPS and the safeguards included in them.

This weekend, representatives from 43 developing countries and from donor countries are coming together in Geneva to discuss how we best can proceed with the Fund. The European countries individually, but equally the European Commission, will have a crucial role to play in order to ensure that we end up with a viable, effective and well-funded mechanism.

We will need to be careful this weekend to build up the consensus needed on the ways in which the Fund works in countries and on its governance. We need to agree on the next steps, and on the key role of the Secretary-General in ensuring that those steps lead to a viable, well financed and properly managed funding mechanism. We need to be able to confirm that developing country governments are comfortable with the process through which the Fund is being taken forward. We need to be clear that this is an international Fund, backed by the UN, but driven jointly by governments of developing and industrialized governments in ways that reflect good development practice. We need to establish an entity that is seen as an attractive proposition for those who wish to invest in health and development outcomes.

A positive outcome from this weekend's meeting will be a great boost for UNGASS on HIV/AIDS in New York at the end of June, the G8 in July and the plans being taken forward by the Swedish and Belgian Presidencies during this vital year. This will set us well on track for the achievement of International Development Goals by 2015. This means innovative ways of working within the UN system as a whole, and within WHO in particular. Business as usual is not an option - for the UN, nor for countries that will call on the resources within the Fund or the mechanisms used for spending its resources.

Our own work at WHO is changing in this direction. Through GAVI, though Roll Back Malaria, through Stop TB and other partnerships, we have built up experience in how to follow through globally agreed interventions all the way to country action. We see what can be achieved if additional resources become available for country level action, especially if the availability of resources is linked to the achievement of agreed milestones for health outcomes. At the same time, we are directing research efforts and policy development in areas where new technologies and approaches are needed - such as in the development of treatment regimes for people with AIDS in resource-poor settings.

In countries, WHO's role will be that of a central partner of the government in planning programmes, in reforming the health sector and in developing policies. We seek ways to work more effectively with other UN system agencies, and - of course - with ongoing programmes for poverty reduction supported by the bilateral development agencies and development banks.

There have been some recent and promising examples of ways in which the WHO's country teams can help to promote sustained success.

In Cambodia, WHO has worked closely with the Government and civil society to combat HIV/AIDS. Through developing a national policy for "100% condom use", planning and executing a well organized health campaign, and ensuring coordinated action in other sectors, we have seen that HIV infection rates have shown a declining trend in recent years. For example, the rate of HIV infections among sex workers below 20 years of age dropped from more than 40% in 1998 to 23% in 2000.

In Indonesia, WHO has been intimately involved in the Government's decentralization of the health system, ensuring that a devolution of responsibility is matched by competence and resources at local level.

In Nigeria, WHO is working shoulder to shoulder with the government of President Obasanjo, who, of course taken a leading role in placing health centrally in his own - and Africa's development agenda. Our aim is to make WHO an effective partner in countries' efforts to spur development through making cost-effective investments in health.

Partnerships have become a central feature of our strategy to make best use of our strengths and focus on outcomes. The partnership with the European Commission has developed in a very constructive way over the past two years - particularly through country-level action. It has also been heartening to see the way in which individual members of the Union have been so supportive of the new agenda. I hope that with the stated European commitment on health in development, our collaboration will be further strengthened in the months and years to come.

We have a common task to reduce poverty and encourage equitable development for all those who so far have been left behind in the sweeping wave of globalization. I would like the resources of WHO - at country, regional and global levels, to be used to their best effect in the pursuit of this vital agenda. I look forward to working even more closely with you to ensure that this goal is fulfilled.

Thank you.

Return to Director-General's main page